Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study

    Blood Purification Date published:

  • Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?

    Nephrology Dialysis Transplantation Date published:

  • Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial

    Date published:

  • SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

    The Lancet Diabetes & Endocrinology Date published:

  • Ethical Issues in Pragmatic Cluster-Randomized Trials in Dialysis Facilities

    American Journal of Kidney Diseases Date published:

  • Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review

    BMJ Global Health Date published:

  • Varying Association of Extended Hours Dialysis with Quality of Life

    Clinical Journal of the American Society of Nephrology Date published:

  • Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering

    Canadian Medical Association Journal Date published:

  • Representativeness of Randomized Clinical Trial Cohorts in End-stage Kidney Disease

    JAMA Internal Medicine Date published:

  • Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Chronic Kidney Disease and Coronary Artery Disease

    Journal of the American College of Cardiology Date published:

  • Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

    Journal of the American Society of Nephrology Date published:

  • Canagliflozin and Renal Outcomes in Diabetic Nephropathy

    New England Journal of Medicine Date published:

  • Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

    Circulation Date published:

  • Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

    Diabetologia Date published: